an Experimental Test of the Relationship between Electronic Nicotine Delivery System Use and alcohol Consumption.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
hershberger (2021)
The interaction of nicotine concentration and device power on electronic nicotine delivery system (ENDS) abuse liability among exclusive ENDS users and dual users of ENDS and combustible cigarettes.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
hoetger (2022)
Trends and associated risks in adolescent substance use: E-cigarette use and nitrous oxide use.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
huizink (2022)
Is the use of e-cigarettes for smoking cessation associated with alcohol consumption?
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Jackson (2020)
E-cigarette use is associated with susceptibility to tobacco use among australian young adults.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Jongenelis (2019)
a comparison of product dependence among cigarette only, ENDS only, and dual users: Findings from Wave 3 (2015-2016) of the PaTh study.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Kaplan (2020)
Blood Nicotine Predicts the Behavioral Economic abuse Liability of Reduced-Nicotine Cigarettes.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Kaplan (2022)
Electronic Cigarette Use, Misuse, and harm.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Kathuria (2022)
Electronic cigarette use and risk of cigarette and smokeless tobacco initiation among adolescent boys: a propensity score matched analysis.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Keller-hamilton (2021)
Reinforcement enhancement by nicotine: a novel abuse-liability assessment of e-cigarettes in young adults.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Kirshenbaum (2022)